1. Home
  2. ROMA vs TECH Comparison

ROMA vs TECH Comparison

Compare ROMA & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roma Green Finance Limited

ROMA

Roma Green Finance Limited

HOLD

Current Price

$1.19

Market Cap

118.5M

Sector

Finance

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$64.26

Market Cap

9.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROMA
TECH
Founded
2018
1976
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.5M
9.2B
IPO Year
2024
1989

Fundamental Metrics

Financial Performance
Metric
ROMA
TECH
Price
$1.19
$64.26
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
$70.46
AVG Volume (30 Days)
10.5K
1.6M
Earning Date
12-26-2025
02-04-2026
Dividend Yield
N/A
0.49%
EPS Growth
N/A
N/A
EPS
N/A
0.49
Revenue
$1,640,101.00
$1,216,732,000.00
Revenue This Year
N/A
$2.33
Revenue Next Year
N/A
$7.05
P/E Ratio
N/A
$133.64
Revenue Growth
59.60
3.85
52 Week Low
$0.58
$46.01
52 Week High
$4.66
$79.28

Technical Indicators

Market Signals
Indicator
ROMA
TECH
Relative Strength Index (RSI) 20.98 63.74
Support Level $1.16 $58.40
Resistance Level $1.75 $66.48
Average True Range (ATR) 0.34 1.56
MACD -0.06 0.77
Stochastic Oscillator 14.68 76.35

Price Performance

Historical Comparison
ROMA
TECH

About ROMA Roma Green Finance Limited

Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage, and overcome various business matters arising from such factors related to ESG, sustainability and climate change. Geographically, the company generates its revenue from Hong Kong and Singapore.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: